About US
Contact us
-
Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019 Decision Resources, one of the world's leading research and advisory firms for pharmace2010/10/12
-
Abbott to withdraw sibutramine from Canadian marketAbbott to withdraw sibutramine from Canadian market Abbott will voluntarily withdraw sibutramine from the Canadian market after discussion with Health Canada. Sibutramine is marketed by Abbott in2010/10/12
-
BASF to establish STYROLUTION as a leading company in styrenics· Existing BASF styrenics activities to be transferred to separate companies · STYROLUTION to focus on customers in styrenics business Ludwigshafen, Germany – October 7, 2010 – BASF is continui2010/10/11
-
Biologists determine three-dimensional structure of molecule involved in HIV, cancerIn a technical tour de force, structural biologists funded by the National Institutes of Health have determined the three-dimensional structure of a molecule involved in HIV infection and in many f2010/10/11
-
BASF focuses on Ecovio® and Ecoflex®· Expanded Ecoflex plant in Ludwigshafen to go on stream at the end of 2010 · BASF expects significant market growth for biodegradable plastics through to 2020 Ludwigshafen , Germany – Octobe2010/10/9
-
Onyx Pharmaceuticals announces delay in NDA filing for carfilzomibOnyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Contr2010/10/9
-
Pharmaxis receives FDA approval to market ARIDOL Test KitPharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today that it has received approval from the U.S. Food and2010/10/8
-
Roche receives development and commercialization rights for danoprevir drugInterMune, Inc. (Nasdaq: ITMN) today announced that it has sold worldwide development and commercialization rights to danoprevir (also known as RG7227 or ITMN-191) to Hoffman-La Roche Inc. and F. Hoff2010/10/8
-
USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tabletsSun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted a tentative approval for its Abbreviated New Drug Application2010/9/30
-
Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discoveryLigon Discovery, the innovator of Small Molecule Microarray technology, today announced that it has partnered with Bayer Schering Pharma AG, Germany, to apply its proprietary Small Molecule Microarray2010/9/30